MESOMesoblast LimitedFeb 27, 2026Q2 2026
Read transcript →Mesoblast Limited (MESO) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$13.93
+1.31%
Mkt Cap $1.99B
MESOMesoblast LimitedFeb 27, 2026MESOMesoblast LimitedAug 29, 2025Q4 2025
Read transcript →MESOMesoblast LimitedFeb 28, 2025Q2 2025
Read transcript →MESOMesoblast LimitedAug 28, 2024Q4 2024
Read transcript →MESOMesoblast LimitedFeb 29, 2024Q2 2024
Read transcript →MESOMesoblast LimitedAug 30, 2023Q4 2023
Read transcript →MESOMesoblast LimitedMay 25, 2023Q3 2023
Read transcript →MESOMesoblast LimitedMar 2, 2023Q2 2023
Read transcript →MESOMesoblast LimitedNov 23, 2022Q1 2023
Read transcript →MESOMesoblast LimitedAug 30, 2022Q4 2022
Read transcript →MESOMesoblast LimitedAug 27, 2020Q4 2020
Read transcript →MESOMesoblast LimitedMay 29, 2020Q3 2020
Read transcript →MESOMesoblast LimitedFeb 29, 2020Q2 2020
Read transcript →MESOMesoblast LimitedNov 26, 2019Q1 2020
Read transcript →MESOMesoblast LimitedAug 29, 2019Q4 2019
Read transcript →MESOMesoblast LimitedMay 30, 2019Q3 2019
Read transcript →MESOMesoblast LimitedNov 15, 2018Q1 2019
Read transcript →MESOMesoblast LimitedAug 29, 2018Q4 2018
Read transcript →MESOMesoblast LimitedMay 31, 2018Q3 2018
Read transcript →MESOMesoblast LimitedFeb 28, 2018Q2 2018
Read transcript →MESOMesoblast LimitedNov 15, 2017Q1 2018
Read transcript →MESOMesoblast LimitedMay 25, 2017Q3 2017
Read transcript →MESOMesoblast LimitedMay 10, 2016Q3 2016
Read transcript →MESOMesoblast LimitedFeb 16, 2016Q2 2016
Read transcript →